Comparison of efficacy and safety among individualized regimens containing clofazimine, linezolid or meropenem-clavulanic acid in treatment of multidrug/extensively resistant tuberculosis: a network meta-analysis
10.3760/cma.j.issn.1674-2397.2017.06.011
- VernacularTitle:含氯法齐明、利奈唑胺、美罗培南-克拉维酸化疗方案治疗耐多药及广泛耐多药结核病的疗效和安全性比较网状荟萃分析
- Author:
Qinglin CHENG
1
;
Li XIE
;
Le WANG
;
Limin WU
;
Min LU
;
Qingchun LI
;
Ke WANG
;
Wei LIU
;
Yifei WU
Author Information
1. 310021,杭州市疾病预防控制中心
- Keywords:
Antitubercular drugs;
Network meta-analysis;
Multidrug/extensively resistant tuberculosis
- From:
Chinese Journal of Clinical Infectious Diseases
2017;10(6):452-460
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the efficacy and safety among individualized regimens ( IR ) containing clofazimine ( Cfz ) , linezolid ( Lzd ) or meropenem-clavulanic acid ( MC ) in treatment of multidrug/extensively resistant tuberculosis (MDR/XDR-TB) by using network meta-analysis.Methods Randomized controlled trials ( RCTs) and observational studies of Cfz-IR, Lzd-IR and MC-IR regimens in the treatment of MDR/XDR-TB published from January 2000 to August 2017 at home and abroad were retrieved.The literature was screened according to inclusion and exclusion criteria.The quality of the literature was evaluated and valid data were extracted.The efficacy and safety of Cfz-IR, Lzd-IR and MC-IR in the treatment of MDR/XDR-TB were directly and indirectly compared by network meta-analysis.Relative risk ( RR) or relative comparative effect ( Mean) or adverse reaction rate and 95%confidence interval ( CI) were used as indicators of systematic evaluation , and Berg' s funnel plot was used for the existing publication bias.Results A total of 20 papers and 21 studies were included.There were 2490 cases in the study group and 2303 cases in the control group included.According to the direct comparison of the network meta-analysis, the efficacy for treatment of MDR/XDR-TB of Lzd-IR ( RR=1.18, 95% CI 1.02-1.36, Z=2.28, P <0.05) and MC-IR(RR=1.23,95%CI 1.01-1.50,Z=2.10,P<0.05)was better than that of IR in control group.The rates of adverse reactions of Lzd-IR, Cfz-IR and MC-IR were 29%(95%CI 0.24-0.35), 21%(95%CI 0.13-0.28) and 7% (95% CI 0.03-0.10), respectively.The top-down efficacy outcomes of the 4 individualized chemotherapy regimens were MC-IR (66.4%), Lzd-IR(22.6%), Cfz-IR (10.0%) and IR without Cfz, Lzd or MC (1.0%).The fitting model showed that MC-IR (Z=3.04, P<0.05) and Lzd-IR (Z=2.31, P<0.05) significantly shortened the "off"time compared with IR without Cfz, Lzd or MC.Conclusion The network meta-analysis shows that the efficacy and safety of regimen MC-IR are significantly higher than those of Lzd-IR and Cfz-IR in treatment of MDR/XDR-TB.